is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Detailed information on Genentech, Inc. required for business and competitor intelligence needs
A study of the major internal and external factors affecting Genentech, Inc. in the form of a SWOT analysis
An in-depth view of the business model of Genentech, Inc. including a breakdown and examination of key business segments
Intelligence on Genentech, Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about Genentech, Inc., such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Genentech (or 'the company'), a wholly-owned subsidiary of the Roche Group, is a leading biotechnology company. The company is engaged in the discovery, development, manufacture and commercialization of medicines to treat patients with serious or life-threatening medical conditions. It is headquartered in South San Francisco, California, and has about 12,300 full-time employees.
Reasons to Purchase:
Gain understanding of Genentech, Inc. and the factors that influence its strategies
Track strategic initiatives of the company and latest corporate news and actions
Assess Genentech, Inc. as a prospective partner, vendor or supplier
Support sales activities by understanding your customers' businesses better
Stay up to date on Genentech, Inc.’s business structure, strategy and prospects